Mark Sterritt (British Business Bank), Adam Christie (Calcivis), Paul Callaghan (Scottish National Investment Bank) and David Milroy (Maven Capital Partners).
Facebook
LinkedIn
X

AN Edinburgh-based biotechnology company has secured a substantial £5 million in funding to propel its innovative dental technology into the

CEO David Brennan
man focusing on camera equipment outside
Man in suit touching text 'venture capital' with business icons in honeycomb shape beside him

Other articles from Silicon Scotland